US 11225506
Cell penetrating peptides and methods of making and using thereof
granted A61KA61K38/05A61K38/12
Quick answer
US patent 11225506 (Cell penetrating peptides and methods of making and using thereof) held by Entrada Therapeutics, Inc. expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Entrada Therapeutics, Inc.
- Grant date
- Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K38/05, A61K38/12, A61K38/465, A61K47/64